Physician profile
Adam Jacoby
NPI 1841677192
$43,306.00
in general payments reported to CMS, 2019-2025
13 companies · $303 in 2025
The $303 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41K · 2022: $403 · 2023: $607 · 2024: $646 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,555.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $40,000.00 | 2021 | |
| Gotham Surgical Solutions & Devices, INC. | $1,346.19 | 2021-2022 | |
| Integra Lifesciences Corporation | $577.13 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Polynovo North America LLC | $574.65 | 2024-2025 | Novosorb Btm |
| Rti Surgical, INC | $257.63 | 2022-2023 | |
| Allergan, INC. | $147.95 | 2022 | |
| Endo Pharmaceuticals INC. | $146.92 | 2021 | |
| Access Pro Medical, LLC | $123.33 | 2023 | Matriderm |
| Avita Medical Americas, LLC | $33.87 | 2025 | Recell, Cohealyx, Permeaderm |
| Tela Bio, INC. | $32.53 | 2024 | Ovitex 2s |
| Abbvie INC. | $31.25 | 2024 | |
| Checkpoint Surgical, INC | $21.60 | 2024 | Checkpoint Stimulators |
| Kci USA, INC. | $12.95 | 2023 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Jacoby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.